Liberum Capital Reiterates “Sell” Rating for Reckitt Benckiser Group (RB)
Reckitt Benckiser Group (LON:RB)‘s stock had its “sell” rating reaffirmed by equities research analysts at Liberum Capital in a research note issued to investors on Monday, StockRatingsNetwork.com reports. They currently have a GBX 3,700 ($59.27) price objective on the stock. Liberum Capital’s price objective indicates a potential downside of 18.66% from the company’s current price.
Several other analysts have also recently commented on the stock. Analysts at JPMorgan Chase & Co. reiterated a “neutral” rating on shares of Reckitt Benckiser Group (LON:RB) in a research note to investors on Thursday, September 12th. Separately, analysts at Sanford C. Bernstein reiterated an “outperform” rating on shares of Reckitt Benckiser Group (LON:RB) in a research note to investors on Thursday, September 12th. They now have a GBX 5,450 ($87.30) price target on the stock. Finally, analysts at Credit Suisse reiterated a “neutral” rating on shares of Reckitt Benckiser Group (LON:RB) in a research note to investors on Wednesday, September 11th. They now have a GBX 4,650 ($74.48) price target on the stock.
Seven analysts have rated the stock with a sell rating, thirteen have given a hold rating and six have assigned a buy rating to the company’s stock. The company has a consensus rating of “Hold” and a consensus price target of GBX 4,583.73 ($73.42).
Reckitt Benckiser Group (LON:RB) traded down 1.11% on Monday, hitting GBX 4549.00. 692,470 shares of the company’s stock traded hands. Reckitt Benckiser Group has a one year low of GBX 3561.00 and a one year high of GBX 4986.00. The stock has a 50-day moving average of GBX 4508.81 and a 200-day moving average of GBX 4644.. The company’s market cap is £33.232 billion.
Reckitt Benckiser Group Plc is manufacturer and marketer of branded products in household, health and personal care, selling a range through over 60 operating companies into nearly 200 countries.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.